Pearlman D S
Drugs. 1976;12(4):258-73. doi: 10.2165/00003495-197612040-00002.
Antihistamines are a diverse group of drugs which possess the ability to inhibit various histaminic actions. By and large, they bear a certain structural resemblance to histamine, and act principally to prevent histamine-receptor interaction through competition with histamine for histamine receptors. Consequently, they are helpful therapeutically in preventing, rather than reversing, histaminic actions. Individual antihistaminic drugs act to inhibit histaminic action at one or another histamine receptor (H1 or H2-receptor), but not at both receptors. The large number of antihistaminics which have been available for many years and employed chiefly as 'antiallergic' drugs are classified as H1-receptor inhibitors; they are most effective therapeutically in inhibiting manifestations of histamine-induced wheal and erythema formation and pruritus. H2-receptor inhibitors, agents which are able to inhibit histamine-induced gastric acid secretion, have been developed more recently. Antihistaminics in general and H1-receptor inhibitors in particular, exert a wide variety of pharmacological activities. Their use is frequently accompanied by undesirable side-effects, notably CNS depression, dryness of mucous membranes, and gastrointestinal effects. Used judiciously and in proper dosage, antihistaminic drugs are helpful in the control of allergic disorders, allergic rhinitis and urticaria in particular; newly developed H2-receptor inhibitors show therapeutic promise in the treatment of peptic ulceration.
抗组胺药是一类具有抑制多种组胺作用能力的药物。总体而言,它们在结构上与组胺有一定相似性,主要通过与组胺竞争组胺受体来阻止组胺 - 受体相互作用。因此,它们在治疗上有助于预防组胺作用,而非逆转组胺作用。个别抗组胺药作用于抑制一种或另一种组胺受体(H1或H2受体)的组胺作用,但并非同时作用于两种受体。多年来可用且主要用作“抗过敏”药物的大量抗组胺药被归类为H1受体抑制剂;它们在治疗上最有效地抑制组胺诱导的风团和红斑形成以及瘙痒的表现。H2受体抑制剂,即能够抑制组胺诱导的胃酸分泌的药物,是最近才开发出来的。一般的抗组胺药,尤其是H1受体抑制剂,具有多种药理活性。它们的使用常常伴随着不良副作用,特别是中枢神经系统抑制、粘膜干燥和胃肠道效应。合理使用并采用适当剂量时,抗组胺药有助于控制过敏性疾病,特别是过敏性鼻炎和荨麻疹;新开发的H2受体抑制剂在治疗消化性溃疡方面显示出治疗前景。